Nutrition Product List

Laennec inj.Human placenta hydrolysate 1 ml/ml Improvement of liver function in chronic liver diseases

Laennec Inj. Vial

P L A C E N T A

Megagreen Inj.

Ascorbic acid 500 mg/ml

1. Prevention and treatment of vitamin C de�ciency: scurvy, etc2. Vitamin C Demand inc rease: Pregnancy, Lactation, Execessive Physical labor 3. Suspected to be involved in metabolic disorders or vitamin de�ciencies : 3-1. Disorder of bone matrix formation and bony obstacle after bone fracture 3-2 Stains, freckles, hyperpigmentation after in�ammation 3-3 Photodermatitis, etc

Fursultamin Inj.

Fursultiamine hydrochloride 5.46 mg/ml

1. Wernicke syndrome, beriberi, Heart disease 2. Suspected vitamin b1 de�ciency or disturbances of metabolism 2-1 Neuralgia, muscular pain, arthralgia 2-2 Peripheral neuritis, peripheral nerve paralysis 2-3 Myocardial matabolism disorder 2-4 Gastrointestinal disorder (ex. constipation) 2-5 Postoperative paralytic ileus

GCvitaD Inj.

Cholecalciferol 5 mg/ml (200,000 IU)Prevention and treatment of vitamin D de�ciency from Vitamin D-de�cient aged person and adolescent

D-Panthenol 250mg/ml

1. Prevention and treatment of de�ciency of D-Panthenol2. Supply Panthotenic acid in case of increasing demand or insu�cient

intake of panthontenic acid from meal(wasting disease, hyperthyroid -ism, a pregnant woman, lactating women and so on)

Megavitasix Inj.

Pyridoxine Hydrochloride 25 mg/ml

1.Prevention and treatment of vitamin B6 de�ciency disease2. Vitamin B6 dependency3. In cases vitamin de�ciency or metabolic disorders: commissural cheilitis, acute and chronic eczema, seborrheic eczema

peripheral neuritis, radiation sickness

GCvitaonetwo Inj.

Hydroxocobalamin 2.5 mg/mlAcute neuritis, multiple neuritis, sciatic neuralgia, rheumatoid neuralgia, shoulder-arm-neck syndrome, radiculopathy, scapula periarthritis, Neural -gia by cancer and trauma, Neuralgia by herpes zoster and migraine

V I T A M I N S

Brand name Active ingredient Indication and usage

Brand name Active ingredient Indication and usage

GCtathione Inj. 600mg / 1200mg

Glutathion (reduced) 600 mg / 1200 mg Prevention of cisplatin(platinum)-induced neuropathy

GCthioctic acid Inj.

Thioctic acid 5 mg/ml

1. Increase demand of thiotic acid (Execessive physical labor)2. Leigh syndrome (subacute necrotizing encephalitis)3. Toxicity (streptomycin, Kanamycin) and labyrinthine deafness

GCNAC Inj.

Acetylcysteine 100 mg/ml

1. Di�cult Sputum expectoration from bronchial diseases with thick dense sputum ; acute bronchitis, chronic bronchitis, asthmatic bronchitis, bron-chial asthma, laryngopharyngitis, sinusitis, cystic �brosis, Postoperative pulmonary commplication

2. Detoxication of paracetamol(acetaminophen) intoxication

A N T I - O X I D A N T S

Meganesium10% Inj.

Magnesium sulfate 10% 0.1 g/ml

1. Convulsion2. Eclampsia3. Supply the electrolyte (hypomagnesemia)4. Uterus rigidity (parturifacient)

GCtrace Inj.

Zinc sulfate hydrate 22.0 mg/ml (Zn 5.0 mg/ml) Cupric sulfate hydrate 3.93 mg/ml(Cu 1.0 mg/ml) Manganese sulfate hydrate 1.54 mg/ml(Mn 0.5 mg/ml) Chromic choride hydrate 0.051 mg/ml(Cr 0.01 mg/ml)

Use as an additive for Total Parenteral Nutrition (TPN)

GCzinc Inj.

Zinc Sulfate Hydrate 4.4 mg/ml(Zn 1 mg/ml)

Zinc level restoration during Total Parenteral Nutrition (TPN)

GCcalcium gluconate Inj.

Gluconate calcium hydrate 104.2 mg/ml(Ca 9.765 mg/ml)

Tetany due to hypocalcemia or assocated symptoms (urticaria, hyper-kalemia, magnesium intoxication)

M I N E R A L S

Brand name Active ingredient Indication and usage

Sodiumchloride 0.9% Kit

Sodium chloride 0.9% 1. Supply of water and electrolyte de�ciency (sodium de�cit, chlorine de�cit)2. Dissolution diluent of injections

5%Dextrosekit

Dextrose 5%1. Dehydration, specially water supply of water de�cit.2. Dissolution diluent of injections

S O L U T I O N

GCcholine Inj.

Choline alfoscerate 0.25 g/ml

A secondary symptom and denatured or degenerative organic psychogenic syndrome due to cerebral vascular defect (decreased memory, confusion, orientation and sensory disorder due to decreased drive and spontaneity, decreased concentration), Change of emotion and behavior, mood irritability, stimulation hypersensitiveness,Apathy, senile pseudo-depression

GCcartin Inj.

L-carnitine 0.2 g/ml

1. Primary and secondary carnitine de�ciency2. Myocardial metabolic disorder by ischemic heart disease: angina, acute myocardial infarction3. The prevention and treatment of carnitine de�ciency in patients with

end stage renal disease who are undergoing dialysis

Hishiphagen-C Inj.

In 20 mlAmmonium glycyrrhizinate 53 mgGlycine 400 mgL-cysteine hydrochloride 20 mg

1. Urticaria2. Ezema3. Allergic dermatitis4. Adjuvant therapy for drug addiction5. Improvement liver function in chronic liver disease

M I S C E L L A N E O U S

Sodium bicarbonate 84mg/ml Dr. Paul Lohmann GmBH (Germany)

GCsodiumbicarbonate Inj.